Ellomay Capital (NYSE: ELLO) awards 1,000 stock options to board director

Rhea-AI Filing Summary

Ellomay Capital director Ben Simon Dorit received an annual grant of 1,000 stock options on August 1, 2026 under the issuer's 1998 Share Option Plan for Non-Employee Directors. The options cover 1,000 Ordinary Shares, have an exercise price of 19.6000, first become exercisable on August 1, 2027, and expire on August 1, 2036, subject to her continued board service.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Ben Simon Dorit

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy) F1, F2	1,000	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 1,000 shares (Direct)

Footnotes (2)

1. F1. On August 1, 2026, the Reporting Person received an annual grant of options under the terms and conditions set forth in the Issuer's 1998 Share Option Plan for Non-Employee Directors.
2. F2. Subject to the Reporting Person serving as a member of the Issuer's Board of Directors on such date.

Key Figures

Options granted: 1,000 Underlying Ordinary Shares: 1,000 Exercise price: 19.6000 per share +3 more

6 metrics

Options granted 1,000 Annual stock option grant to director on 2026-08-01

Underlying Ordinary Shares 1,000 Number of Ordinary Shares subject to the options

Exercise price 19.6000 per share Price at which Ordinary Shares may be purchased upon exercise

Exercise date 2027-08-01 First date the options become exercisable, subject to continued board service

Expiration date 2036-08-01 Date on which the options expire if not exercised

Derivative holdings after grant 1,000 options Total options held following this reported grant

Key Terms

Stock Option (right to buy), Ordinary Shares, 1998 Share Option Plan for Non-Employee Directors, exercise date

4 terms

Stock Option (right to buy) financial

"Security title reported as Stock Option (right to buy) with underlying Ordinary Shares"

Ordinary Shares financial

"Underlying security title specified as Ordinary Shares of Ellomay Capital"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

1998 Share Option Plan for Non-Employee Directors financial

"Annual grant made under the Issuer's 1998 Share Option Plan for Non-Employee Directors"

exercise date financial

"Options carry an exercise date of 2027-08-01 subject to board service"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/04/2026 - 04:11 PM Accepted by SEC EDGAR 08/04/2026 - 04:10 PM Learn about SEC filing dates

FAQ

What insider transaction did Ellomay Capital (ELLO) report for Ben Simon Dorit?

Ben Simon Dorit received an annual grant of 1,000 stock options in Ellomay Capital. The options relate to 1,000 Ordinary Shares and were granted under the company’s 1998 Share Option Plan for Non-Employee Directors on August 1, 2026.

What is the exercise price of the options granted to the Ellomay Capital (ELLO) director?

The granted stock options have an exercise price of 19.6000 per share. They give the director the right to buy Ellomay Capital Ordinary Shares at this price once the options become exercisable.

When can the granted Ellomay Capital (ELLO) options be exercised and when do they expire?

The options first become exercisable on August 1, 2027 and expire on August 1, 2036. This provides a window of several years during which the director may choose to exercise the award.

How many Ellomay Capital (ELLO) Ordinary Shares underlie the director’s new options?

The option grant covers 1,000 underlying Ordinary Shares of Ellomay Capital. If fully exercised, the director could acquire up to this number of Ordinary Shares at the specified exercise price.

Are the Ellomay Capital (ELLO) options subject to any service conditions?

Yes. Exercisability on August 1, 2027 is subject to the director continuing to serve on Ellomay Capital’s Board on that date. This links the benefit of the grant to ongoing board service.

Was the Ellomay Capital (ELLO) option grant made under a Rule 10b5-1 trading plan?

No. The report indicates the Rule 10b5-1 trading plan checkbox was not selected. The grant is described as an annual option award under the 1998 Share Option Plan for Non-Employee Directors.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ben Simon Dorit

(Last) (First) (Middle)

18 ROTHSCHILD BLVD.

(Street)

TEL AVIV 6688121

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ellomay Capital Ltd. [ ELLO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol
[ELLO]

3. Date of Earliest Transaction (Month/Day/Year)
08/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$19.6	08/01/2026(1)		A		1,000		08/01/2027(2)	08/01/2036	Ordinary Shares	1,000	$0	1,000	D

Explanation of Responses:

1. On August 1, 2026, the Reporting Person received an annual grant of options under the terms and conditions set forth in the Issuer's 1998 Share Option Plan for Non-Employee Directors.

2. Subject to the Reporting Person serving as a member of the Issuer's Board of Directors on such date.

	/s/ Dorit Ben Simon	08/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)